HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT Newswires Live
2024-12-24

HCW Biologics (HCWB) fell nearly 11% in recent Monday trading after the company said it received a delisting notice from Nasdaq.

The company said it faces potential delisting following its failure to regain compliance with Nasdaq's requirements for continued listing. It was notified in June by exchange regulators that its market value of listed securities, or MVLS, was below the required $50 million threshold for 30 straight business days.

HCW Biologics said it intends to timely request a hearing before the Nasdaq Hearing Panel to avoid delisting and to discuss how it plans to regain compliance with the MVLS rule.

Price: 0.40, Change: -0.05, Percent Change: -10.91

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10